Nipocalimab for treating generalised myasthenia gravis [ID6562]

  • Awaiting development
  • GID-TA11492
  • Expected publication date: TBC
To appraise the clinical and cost effectiveness of Nipocalimab within its marketing authorisation for treating myasthenia gravis ID6562